Replies to post #98848 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

It’s also different in that GOG only measured 12 month overall survival. Different endpoints.

[ubmmg]

Even though it’s apples to oranges, do you agree that the results are impressive? Very troubling that Advaxis had the data almost 4 years ago and we are still in square one. Iovance will be a leader in this area of the cervical cancer. As for the primary and the secondary outcome measures, Advaxis also had ORR. But it was not impressive and wasn’t pumped as the 12-months survival.